Skip to main content

Table 6 Summary of data points for retrospective chart review

From: Prioritization of head and neck cancer patient care during the COVID-19 pandemic: a retrospective cohort study

Demographics

Age (Yrs)

Sex (M/F)

Comorbidities (PMHx/PSHx)

Smoking (Y/N)

Alcohol (Y/N)

Presentation

Date Onset of symptoms (mm-yyyy)

Date seen first by any doctor for index symptoms (dd-mm-yyyy)

Date referral made to OTL-HNS (dd-mm-yyyy)

Date first seen by OTL-HNS (dd-mm-yyyy)

Was the first encounter with OTL-HNS by telemedicine or in-person? (Y/N)

If the first encounter was by telemedicine, when was the first in-person visit? (dd-mm-yyyy)

Workup

Date first biopsy made (dd-mm-yyyy)

Date first histopathologic/cytopathologic diagnosis made (dd-mm-yyyy)

Date presented at HNC tumor board (dd-mm-yyyy)

Date first imaging—CT, MRI, PET/CT (dd-mm-yyyy)

Tumor Characteristics

Cancer site/subsite

Cancer type

AJCC stage TNM

Treatment

Tumor board recommendation of treatment

Date Start of treatment: Chemo and/or radiotherapy start date, or surgery date if primary surgery (dd-mm-yyyy)

Date Adjuvant CTX and/or RTX started, if had surgery first (dd-mm-yyyy)

Date surgical pathology reported (dd-mm-yyyy)

Did the treatment have curative intent or palliative only? (Y/N)

Date CTX and/or RTX completed (dd-mm-yyyy)

Post-Treatment

Postoperative complications

Length of postoperative hospital stay

Chemo/radiotherapy complications